Crossmark

A novel alkylating deacetylase inhibitor molecule EDO-S101 in combination with cytarabine synergistically enhances apoptosis of acute myeloid leukemia cells

Crossref DOI link: https://doi.org/10.1007/s12032-019-1302-0

Published Online: 2019-08-01

Published Print: 2019-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jin, Jingrui

Mao, Shihui

Li, Fenglin

Li, Xia

Huang, Xin

Yu, Mengxia

Guo, Wenjian

Jin, Jie https://orcid.org/0000-0002-8166-9915
Funding

Funding for this research was provided by:

Major International Joint Research Programme (81820108004)

National Natural Science Foundation of China (81700137)
License Information

Text and Data Mining valid from 2019-08-01

Version of Record valid from 2019-08-01
More Information

Article History

Received: 8 May 2019

Accepted: 24 July 2019

First Online: 1 August 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: Informed consents were acquired from patients according to institutional guidelines.

Document is current

Any future updates will be listed below